je.st
news
Expected Toxicity of Claimed Immunoconjugates Thwarts Showing of...
2016-03-09 05:27:50| Biotech - Topix.net
Expected Toxicity of Claimed Immunoconjugates Thwarts Showing of Prima Facie Obviousness ) In an inter partes review proceeding, the Patent Trial and Appeal Board upheld the patentability of Phigenix's patent claims that were challenged on the basis of obviousness. Phigenix, Inc. v.
Tags: of
showing
expected
claimed
Category:Biotechnology and Pharmaceuticals
Latest from this category |
All news |
||||||||||||||||||||
|
|
||||||||||||||||||||